Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia John D. GraingerThomas KühneNichola Cooper Review Article Open access 26 July 2021 Pages: 2143 - 2154
Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature Zoia Ehsan KhattakHamza HashmiFaiz Anwer Review Article 27 July 2021 Pages: 2155 - 2172
Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study Giulio GiordanoMariasanta NapolitanoAlessandro Lucchesi Original Article Open access 02 December 2020 Pages: 2173 - 2179
Clinical analysis and a novel risk predictive nomogram for 155 adult patients with hemophagocytic lymphohistiocytosis Mengxin LuYanghao XieMeifang Han Original Article 12 May 2021 Pages: 2181 - 2193
Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals Can BoğaSüheyl AsmaHakan Özdoğu Original Article 25 May 2021 Pages: 2195 - 2202
Obesity and diabetes mellitus in patients with sickle cell disease Tim JangGeorge MoSeah H. Lim Original Article 20 June 2021 Pages: 2203 - 2205
Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients Jing MaXiaofei AiZeng Cao Original Article Open access 15 May 2021 Pages: 2207 - 2214
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study Xuelin DouFangyuan ZhengQian Jiang Original Article 05 June 2021 Pages: 2215 - 2228
Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms Le YinSisi XieHongling Peng Original Article 06 July 2021 Pages: 2229 - 2240
Acute promyelocytic leukemia derived extracellular vesicles conserve PML-RARα transcript from storage-inflicted degradation: a stable diagnosis tool in APL patients Mohieddin BarzegarMehdi Allahbakhshian FarsaniMohammad Hossein Mohammadi Original Article 08 July 2021 Pages: 2241 - 2252
Analysis of real-world data in patients with relapsed/refractory diffuse large B cell lymphoma who received salvage chemotherapy in the rituximab era Shigeo FujiShuhei KidaJun Ishikawa Original Article 09 November 2020 Pages: 2253 - 2260
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients Beatrice CasadeiLisa ArgnaniPier Luigi Zinzani Original Article Open access 10 December 2020 Pages: 2261 - 2268
Low absolute neutrophil count during induction therapy is an adverse prognostic factor in childhood acute lymphoblastic leukaemia Xiaoyan ChenChao LiuXiaofan Zhu Original Article 14 January 2021 Pages: 2269 - 2277
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies Theodoros P. VassilakopoulosSotirios G. PapageorgiouPhivi Rondogianni Original Article 01 February 2021 Pages: 2279 - 2292
Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL Caiqin WangYu WangZhiming Li Original Article 15 May 2021 Pages: 2293 - 2302
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy Gloria IacoboniMarc SimóPere Barba Original Article 08 July 2021 Pages: 2303 - 2310
Health-related quality of life in patients with multiple myeloma participating in a multidisciplinary rehabilitation program Lene Kongsgaard NielsenRikke Faebo LarsenEva Jespersen Original Article 06 January 2021 Pages: 2311 - 2323
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US Faith DaviesRobert RifkinAjai Chari Original Article Open access 10 May 2021 Pages: 2325 - 2337
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis Andrés R. RettigGabriele IhorstJürgen Finke Original Article Open access 01 April 2021 Pages: 2339 - 2350
HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplant Jiaqian QiRui ZhangYue Han Original Article 12 April 2021 Pages: 2351 - 2361
Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6–7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years Xia QinYi-Ping ZhuJing Chen Original Article 14 May 2021 Pages: 2363 - 2373
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation Francesca MarzuttiniAntonella MancusiAntonio Pierini Original Article Open access 28 June 2021 Pages: 2375 - 2380
Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies Junjie CaoRenzhi PeiYing Lu Original Article 06 July 2021 Pages: 2381 - 2385
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials Thomas HeinickeRainer KrahlDietger Niederwieser Original Article Open access 07 July 2021 Pages: 2387 - 2398
Durable remission of T cell lymphoblastic lymphoma relapsing after allogeneic haematopoietic stem cell transplantation with a single low dose of nivolumab Joycelyn P. Y. SimAlbert K. W. LieYok-Lam Kwong Letter to the Editor 21 April 2020 Pages: 2399 - 2402
A patient with cerebral venous sinus thrombosis induced by facial hyaluronic acid injection Liyuan TaoQian WuJinrong Tang Letter to the Editor 09 May 2020 Pages: 2403 - 2405
A case of iron deficiency anemia with extremely hyperferritinemia responds well to oral iron: the first identified hereditary hyperferritinemia cataract syndrome in China Mengqi XuXiaosu ZhaoRongrong Zhu Letter to the Editor 20 May 2020 Pages: 2407 - 2410
Behҫet-like syndrome associated with aplastic anemia successfully treated with mycophenolate mofetil Ivan KrečakMarijana ŠupeVelka Gverić-Krečak Letter to the Editor 13 June 2020 Pages: 2411 - 2413
Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia Paul R. J. AmesSusan Jeffrey Letter to the Editor 17 June 2020 Pages: 2415 - 2416
Type I congenital methemoglobinemia in a Chinese family Jiang JiYang LiuMiao Chen Letter to the Editor 17 June 2020 Pages: 2417 - 2419
Disseminated infection with novel human adenovirus (genotype 79) following allogeneic hematopoietic stem cell transplantation Yuichi IkedaKazushi TanimotoKatsuto Takenaka Letter to the Editor 18 June 2020 Pages: 2421 - 2422
Correction to: Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL Bernd GruhnGrit BrodtJana Ernst Correction Open access 13 July 2021 Pages: 2423 - 2423